miRagen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, will host a conference call and webcast on Thursday, November 7th, at 4:30 p.m.
October 22, 2019
· 1 min read